Literature DB >> 17313631

Aortic valve sclerosis: is it a cardiovascular risk factor or a cardiac disease marker?

Pasquale Palmiero1, Maria Maiello, Andrea Passantino, Sanjeev Wasson, Hanumanth K Reddy.   

Abstract

BACKGROUND: Aortic valve sclerosis, without stenosis, has been associated with an increased cardiovascular mortality and morbidity due to myocardial infarction. However, it is unclear whether it is a cardiovascular risk factor or a cardiac disease marker. The goal of our study is to evaluate the difference in the prevalence of cardiovascular disease and risk factors among patients with or without aortic sclerosis.
METHODS: This observational study compared a group of 142 consecutive subjects with aortic valve sclerosis, assigned as group S, with a group of 101 subjects without aortic sclerosis, assigned as group C. Patients with bicuspid aortic valves and those with antegrade Doppler velocity across aortic valve leaflets exceeding 2.0 m/sec were excluded.
RESULTS: Mean ages of groups S and C were 71 +/- 8, and 68.8 +/- 6 years, respectively (P value = not significant). The prevalence of smoking, diabetes, hypercholesterolemia, hypertension, pulse pressure, left ventricular diastolic dysfunction, atrial fibrillation, and stroke was not significantly different between the two groups. However, there was a significantly higher prevalence of left ventricular hypertrophy (P = 0.05), ventricular arrhythmias (P = 0.02), myocardial infarction (P = 0.04), and systolic heart failure (P = 0.04) in aortic sclerosis group.
CONCLUSIONS: Aortic sclerosis is associated with a higher prevalence of left ventricular hypertrophy, ventricular arrhythmias, myocardial infarction, and systolic heart failure, while the prevalence of cardiovascular risk factors is not different between aortic sclerosis patients and controls. Hence, aortic sclerosis represents a cardiac disease marker useful for early identification of high-risk patients beyond cardiovascular risk factors rate.

Entities:  

Mesh:

Year:  2007        PMID: 17313631     DOI: 10.1111/j.1540-8175.2007.00379.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  3 in total

1.  Assessment of total cardiac repolarization's spatial distribution among patients with aortic sclerosis.

Authors:  Oguzhan Ekrem Turan; Mustafa Ozturk; Abdulselam Ilter; Mustafa Inc; Kayihan Karaman; Gulhanim Kiris; Merih Kutlu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-Ethnic Study of Atherosclerosis.

Authors:  Sammy Elmariah; Joseph A C Delaney; David A Bluemke; Matthew J Budoff; Kevin D O'Brien; Valentin Fuster; Richard A Kronmal; Jonathan L Halperin
Journal:  JACC Cardiovasc Imaging       Date:  2012-08

3.  Real-time imaging required for optimal echocardiographic assessment of aortic valve calcification.

Authors:  Mohamed Yousry; Anette Rickenlund; Johan Petrini; Tomas Gustavsson; Ulrica Prahl; Jan Liska; Per Eriksson; Anders Franco-Cereceda; Maria J Eriksson; Kenneth Caidahl
Journal:  Clin Physiol Funct Imaging       Date:  2012-07-29       Impact factor: 2.273

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.